NfL outperforms other blood tests to predict and diagnose traumatic brain injury

NFL outperforms other blood tests to predict and diagnose traumatic brain injury
Traumatic brain injury protein biomarkers in neuron and astrocyte cells: neurofilament light chain, glial fibrillary acidic protein, tau, ubiquitin c-terminal hydrolase-L1 Credit: Pashtun Shahim, MD, PhD, NIH Clinical Center

A study from the National Institutes of Health showed that neurofilament light chain (NfL) delivered superior diagnostic and prognostic performance as a blood biomarker for mild, moderate, and severe traumatic brain injury (TBI) when compared to blood proteins glial fibrillary acidic protein, tau, and ubiquitin c-terminal hydrolase-L1. The research was conducted by scientists at the NIH Clinical Center, Bethesda, Maryland, and published in the July 8, 2020, online issue of Neurology.

"This study confirms the sensitivity of serum neurofilament light chain and its value as a biomarker of choice for all stages of brain injury, even when measured months to years after a single mild, moderate or severe ," said Leighton Chan, M.D., M.P.H., chief of the Rehabilitation Medicine Department at the NIH Clinical Center.

The scientists selected and studied four proteins from the brain that collect in the blood after a TBI from patients at the NIH Clinical Center who had mild, moderate, or . The proteins were compared on their ability to distinguish patients with TBI from each other and controls, determine brain injury from 30 days to five years after injury, predict functional outcomes, and compliment advanced brain imaging.

Serum NfL was better than the other proteins at identifying patients with mild, moderate, and severe TBI from each other and controls at a median of seven months after injury. Additionally, serum NfL was the only protein that showed an association to functional outcomes with higher concentrations in the blood of patients with worse or lower outcome.

Serum NfL was the only that distinguished TBI patients from uninjured controls with high accuracy even months to years after the injury. This result suggests that a single TBI may cause long-term neuroaxonal degeneration, which may be detected by measuring serum NfL.

Serum NfL also had the strongest association to advanced brain imaging, such as diffusion tensor MRI scans, than the other proteins. This suggests that serum NfL can provide clinicians with an easier, faster, and cost-effective diagnostic and prognostic option than advanced brain imaging.

"Currently, there is no validated biomarker that can reliably detect the subtle signs of brain injury months to years after a traumatic ," said lead author, Pashtun Shahim, M.D., Ph.D. "Our study shows that the amount of serum NfL was higher even at five years after a single traumatic , while the other proteins we measured in this study, although, detectable in blood, were not high enough to distinguish patients from controls."

Explore further

Blood-based biomarker can detect, predict severity of traumatic brain injury

Journal information: Neurology

Citation: NfL outperforms other blood tests to predict and diagnose traumatic brain injury (2020, July 8) retrieved 29 June 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors